8.87
price down icon1.88%   -0.17
after-market Handel nachbörslich: 8.87
loading

Finanzdaten der Fennec Pharmaceuticals Inc-Aktie (FENC)

Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
Enddatum des Zeitraums 2025-06-30 2025-03-31 2024-12-31 2024-09-30 2024-06-30
Periodenlänge 3 Monate 3 Monate 3 Monate 3 Monate 3 Monate
Revenues
10.30%
9.652
8.751 7.925 6.974 7.262
Operating Expenses
29.55%
12.38
9.559 8.859 12.18 12.30
Benefits Costs and Expenses
100.00%
-
9.916 9.545 - -
Costs And Expenses
24.89%
12.38
9.916 9.545 12.18 12.30
Operating Income/Loss
238.12%
-2.732
-0.808 -0.934 -5.202 -5.039
Nonoperating Income/Loss
17.65%
-0.42
-0.357 -0.686 -0.533 -0.514
Income/Loss From Continuing Operations Before Tax
928.50%
9.652
-1.165 -1.62 6.974 -5.553
Income/Loss From Continuing Operations After Tax
170.56%
-3.152
-1.165 -1.985 -5.735 -5.553
Net Income/Loss
170.56%
-3.152
-1.165 -1.985 -5.735 -5.553
Preferred Stock Dividends And Other Adjustments
-
- - - -
Attributable To Noncontrolling Interest
-
- - - -
Basic Average Shares
0.31%
27.66
27.58 -0.077 27.37 27.30
Diluted Average Shares
0.31%
27.66
27.58 -0.721 27.37 27.30
Basic Earnings Per Share
175.00%
-0.11
-0.04 -0.08 -0.21 -0.20
Diluted Earnings Per Share
175.00%
-0.11
-0.04 -0.08 -0.21 -0.20
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic
-
- - - -
$25.11
price up icon 1.33%
$83.70
price down icon 1.34%
$24.42
price down icon 1.55%
$101.93
price down icon 1.05%
$134.97
price up icon 0.33%
biotechnology ONC
$297.96
price down icon 0.73%
Kapitalisierung:     |  Volumen (24h):